Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
Objective: To evaluate effects of atrial fibrillation (AF) on cardiac biomarkers and outcomes in a trial population of patients with heart failure (HF) with reduced ejection fraction treated with optimal guideline-directed medical therapy. Methods: We performed a secondary analysis of 894 patients i...
Main Authors: | Fouad Chouairi, BS, Justin Pacor, MD, P. Elliott Miller, MD, Michael A. Fuery, MD, Cesar Caraballo, MD, Sounok Sen, MD, Eric S. Leifer, PhD, G. Michael Felker, MD, MHS, Mona Fiuzat, PharmD, Christopher M. O’Connor, MD, James L. Januzzi, MD, Daniel J. Friedman, MD, Nihar R. Desai, MD, MPH, Tariq Ahmad, MD, MPH, James V. Freeman, MD, MPH, MS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454821000382 |
Similar Items
-
NT-proBNP in Isolated Diastolic Dysfunction
by: Kenan İltümür, et al.
Published: (2005-01-01) -
NT-proBNP for risk stratification of pulmonary embolism
by: Hélder Dores, et al.
Published: (2011-12-01) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
by: A Palazzuoli, et al.
Published: (2010-05-01) -
Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report
by: Israa Mahmood, PharmD, et al.
Published: (2021-01-01) -
The effect of metformin treatment on the level of GLP-1, NT-proBNP and endothelin-1 in patients with type 2 diabetes mellitus
by: L.K. Sokolova, et al.
Published: (2020-11-01)